453 related articles for article (PubMed ID: 25342612)
1. Experimental autoimmune uveoretinitis (EAU)-related tissue damage and angiogenesis is reduced in CCL2⁻/⁻CX₃CR1gfp/gfp mice.
Zhao J; Chen M; Xu H
Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7572-82. PubMed ID: 25342612
[TBL] [Abstract][Full Text] [Related]
2. Development of experimental autoimmune uveitis: efficient recruitment of monocytes is independent of CCR2.
Dagkalis A; Wallace C; Xu H; Liebau S; Manivannan A; Stone MA; Mack M; Liversidge J; Crane IJ
Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4288-94. PubMed ID: 19357362
[TBL] [Abstract][Full Text] [Related]
3. The monocyte chemokine receptor CX3CR1 does not play a significant role in the pathogenesis of experimental autoimmune uveoretinitis.
Kezic J; McMenamin PG
Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5121-7. PubMed ID: 20463325
[TBL] [Abstract][Full Text] [Related]
4. Analysis of retinal cellular infiltrate in experimental autoimmune uveoretinitis reveals multiple regulatory cell populations.
Kerr EC; Raveney BJ; Copland DA; Dick AD; Nicholson LB
J Autoimmun; 2008 Dec; 31(4):354-61. PubMed ID: 18838247
[TBL] [Abstract][Full Text] [Related]
5. CCR5-deficient mice develop experimental autoimmune uveoretinitis in the context of a deviant effector response.
Takeuchi A; Usui Y; Takeuchi M; Hattori T; Kezuka T; Suzuki J; Okunuki Y; Iwasaki T; Haino M; Matsushima K; Usui M
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3753-60. PubMed ID: 16186359
[TBL] [Abstract][Full Text] [Related]
6. Suppression of experimental autoimmune uveitis by angiotensin II type 1 receptor blocker telmisartan.
Okunuki Y; Usui Y; Nagai N; Kezuka T; Ishida S; Takeuchi M; Goto H
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2255-61. PubMed ID: 19136706
[TBL] [Abstract][Full Text] [Related]
7. Retinal microenvironment controls resident and infiltrating macrophage function during uveoretinitis.
Robertson MJ; Erwig LP; Liversidge J; Forrester JV; Rees AJ; Dick AD
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2250-7. PubMed ID: 12091424
[TBL] [Abstract][Full Text] [Related]
8. Invariant natural killer T cells play dual roles in the development of experimental autoimmune uveoretinitis.
Satoh M; Namba KI; Kitaichi N; Endo N; Kitamei H; Iwata D; Ohno S; Ishida S; Onoé K; Watarai H; Taniguchi M; Ishibashi T; Stein-Streilein J; Sonoda KH; Van Kaer L; Iwabuchi K
Exp Eye Res; 2016 Dec; 153():79-89. PubMed ID: 27720708
[TBL] [Abstract][Full Text] [Related]
9. Chemokine and chemokine receptor expression during experimental autoimmune uveoretinitis in mice.
Keino H; Takeuchi M; Kezuka T; Yamakawa N; Tsukahara R; Usui M
Graefes Arch Clin Exp Ophthalmol; 2003 Feb; 241(2):111-5. PubMed ID: 12605265
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of tumor necrosis factor activity minimizes target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retina.
Dick AD; McMenamin PG; Körner H; Scallon BJ; Ghrayeb J; Forrester JV; Sedgwick JD
Eur J Immunol; 1996 May; 26(5):1018-25. PubMed ID: 8647162
[TBL] [Abstract][Full Text] [Related]
11. Evidence for selective accumulation of V beta 8+ T lymphocytes in experimental autoimmune uveoretinitis induced with two different retinal antigens.
Egwuagu CE; Mahdi RM; Nussenblatt RB; Gery I; Caspi RR
J Immunol; 1993 Aug; 151(3):1627-36. PubMed ID: 8393049
[TBL] [Abstract][Full Text] [Related]
12. A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens.
Caspi RR; Roberge FG; Chan CC; Wiggert B; Chader GJ; Rozenszajn LA; Lando Z; Nussenblatt RB
J Immunol; 1988 Mar; 140(5):1490-5. PubMed ID: 3346541
[TBL] [Abstract][Full Text] [Related]
13. A novel pathogenic RBP-3 peptide reveals epitope spreading in persistent experimental autoimmune uveoretinitis.
Boldison J; Khera TK; Copland DA; Stimpson ML; Crawford GL; Dick AD; Nicholson LB
Immunology; 2015 Oct; 146(2):301-11. PubMed ID: 26152845
[TBL] [Abstract][Full Text] [Related]
14. Macrophages and dendritic cells in IRBP-induced experimental autoimmune uveoretinitis in B10RIII mice.
Jiang HR; Lumsden L; Forrester JV
Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3177-85. PubMed ID: 10586940
[TBL] [Abstract][Full Text] [Related]
15. The role of the ICOS/B7RP-1 T cell costimulatory pathway in murine experimental autoimmune uveoretinitis.
Usui Y; Akiba H; Takeuchi M; Kezuka T; Takeuchi A; Hattori T; Okunuki Y; Yamazaki T; Yagita H; Usui M; Okumura K
Eur J Immunol; 2006 Nov; 36(11):3071-81. PubMed ID: 17039566
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: protection is independent of IL-10-inducing activity.
Xu H; Strassmann G; Chan CC; Rizzo LV; Silver PB; Wiggert B; Caspi RR
Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):942-50. PubMed ID: 10102291
[TBL] [Abstract][Full Text] [Related]
17. A clinical grading system for retinal inflammation in the chronic model of experimental autoimmune uveoretinitis using digital fundus images.
Xu H; Koch P; Chen M; Lau A; Reid DM; Forrester JV
Exp Eye Res; 2008 Oct; 87(4):319-26. PubMed ID: 18634784
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil-dominant experimental autoimmune uveitis in CC-chemokine receptor 2 knockout mice.
Sonoda KH; Yoshimura T; Egashira K; Charo IF; Ishibashi T
Acta Ophthalmol; 2011 Mar; 89(2):e180-8. PubMed ID: 20584001
[TBL] [Abstract][Full Text] [Related]
19. Caffeic acid phenethyl ester lessens disease symptoms in an experimental autoimmune uveoretinitis mouse model.
Choi JH; Roh KH; Oh H; Park SJ; Ha SM; Kang MS; Lee JH; Jung SY; Song H; Yang JW; Park S
Exp Eye Res; 2015 May; 134():53-62. PubMed ID: 25795054
[TBL] [Abstract][Full Text] [Related]
20. TNFR1-dependent regulation of myeloid cell function in experimental autoimmune uveoretinitis.
Raveney BJ; Copland DA; Dick AD; Nicholson LB
J Immunol; 2009 Aug; 183(4):2321-9. PubMed ID: 19635911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]